Case summary: Application to show trademark use allowed, in writing February 19, 2019 Alan Macek Attraction Inc. v Ethika Inc., 2018 FC 1136
Case summary: Counsel’s Eyes Only designations must be decided on merits February 19, 2019 Alan Macek Arkipelago Architecture Inc. v Enghouse Systems Limited, 2018 FCA 192
Case summary: Abuse under old regulations but not under new February 19, 2019 Peter W. Choe Amgen Inc. v Pfizer Canada Inc.
Case summary: Third-party discovery within discretion of court February 19, 2019 Peter W. Choe Warren Sprigings, Mary McMillan and Kristina Zilic for Hospira Healthcare Corporation, Celltrion Healthcare Co. Ltd., Celltrion, Inc., and Pfizer Canada Inc. (Defendants by counterclaim)
Case summary: Are contractual claims a sword or a shield? February 14, 2019 David Schnittker Farmobile, LLC v Farmers Edge Inc., 2018 FC 1269
Case Summary: Prohibition application dismissed due to non-infringement allegation November 22, 2018 Kiernan A. Murphy Valeant Canada LP / Valeant Canada S.E.C. v Ranbaxy Pharmaceuticals Canada Inc. et al, 2018 FC 847
Case summary: Evidentiary overkill in opposition unnecessary November 22, 2018 David Bowden Tokai of Canada Ltd v Kingsford Products Company, LLC, 2018 FC 951
Case summary: Teva succeeds on patent issues in section 8 case November 21, 2018 Cheryl Cheung Teva Canada Limited v Janssen Inc., 2018 FC 754
Case summary: Plead sufficient facts when amending statement of defence November 20, 2018 Pablo Tseng Specialized Desanders Inc. v Enercorp Sand Solutions Inc. et al., 2018 FC 689
Case summary: Obviousness test not changed by FCA November 20, 2018 Benjamin Pearson Eli Lilly Canada Inc. v Apotex Inc. 2018 FC 736